The global wound evacuators market size is estimated to be valued at US$ 383.3 Million in 2022. Furthermore, amid the increasing incidence of acute and chronic wounds such as diabetic foot ulcers, post-surgical ulcers, venous ulcers, and pressure ulcers, and rising spending on wound care, the overall wound evacuator sales are projected to grow at a steady CAGR of 4.1% between 2022 and 2032, generating revenues worth US$ 593.6 Million by the end of 2032.
| Attributes | Key Statistics |
|---|---|
| Global Wound Evacuators Market CAGR (2022 to 2032) | 4.1% |
| Global Wound Evacuators Market Estimated Value (2022) | US$ 383.3 Million |
| Global Wound Evacuators Market Projected Value (2032) | US$ 593.6Million |
Wound evacuators are medical devices used for the management and treatment of acute and chronic wounds. They are being increasingly used for the extraction of body fluids from patients to facilitate wound healing.
Over the years, wound evacuators have become highly sought-after medical devices used in post-operative wound management for removing drainage from wounds to prevent infection and facilitate wound healing.
The surge in the number of wounds due to accidents and chronic diseases like diabetes is a key factor driving growth in the global wound evacuators market. A sedentary lifestyle and unhealthy eating habits have resulted in the rise of diabetes worldwide. According to the International Diabetes Federation (IDF), the total number of people living with diabetes is expected to rise to 643 million in 2030 and 783 million by 2045.
Diabetes often leads to serious complications like diabetic foot ulcers which are fatal in nature. For instance, various researches have suggested that 30% of people who develop a diabetic foot ulcer will die within 5 years. This will continue to create a conducive environment for wound evacuators market growth during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per FMI, the global demand for wound evacuators is projected to increase at a CAGR of 4.1% between 2022 and 2032, in comparison to the 3% CAGR registered from 2017 to 2021. Growth in the global wound evacuators market is mainly driven by the rising incidence of acute and chronic wounds, increasing healthcare spending, and the growing need for better wound care to reduce complications.
Wound evacuators have become ideal solutions for better wound management used across healthcare facilities. These medical devices allow healthcare professionals to remove infection and facilitate wound healing.
The rising prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous ulcers is a key factor pushing the demand for wound evacuators across the world. As per the International Diabetes Federation (IDF), diabetic foot and lower limb complications affect around 40 to 60 million people with diabetes globally. This rise in the number of diabetic foot ulcers will therefore continue to boost the wound evacuators market growth during the forecast period.
Similarly, rising preference for cost-effective wound treatment and advancements in wound evacuators will create lucrative opportunities for wound evacuator manufacturers in the coming years.
The growing adoption of wound evacuators in homecare settings to minimize the risk of infections and reduce healthcare costs is projected to expand the global wound evacuators market size in the future.
Despite a positive growth trajectory, the global wound evacuators market is facing various challenges that are restraining its growth to some extent. Some of these factors are higher prices of wound evacuators, scarcity of trained professionals, and increasing usage of traditional wound management across lower economies.
Principal Consultant
As per FMI, North America will continue to dominate the global wound evacuators market, accounting for the largest share of 33.9% in 2022. Demand in the North American wound evacuators market is driven by the rising prevalence of chronic diseases, the highly established healthcare industry, increasing spending on wound care, and the heavy presence of leading wound evacuator manufacturers.
Demand for wound evacuators is particularly high across the USA owing to a surge in cases of pressure ulcers and their (pressure ulcers) high morbidity and mortality rates. According to the Agency for Healthcare Research and Quality (AHRQ), over 2.5 million people in the United States develop pressure ulcers each year. This is acting as a catalyst for the growth of the wound evacuators market in the country.
Similarly, rising healthcare spending, an increasing number of hospitals, clinics, and ambulatory centers, and the presence of some of the world’s leading medical device companies are positively impacting the market growth in the region.
In Europe, the market for wound evacuators is growing significantly owing to the high levels of health awareness among people, the surging burden of chronic wounds, booming medical tourism, favorable government support, and increasing usage of wound evacuators in chronic wound management. According to FMI, Europe holds a share of 27.4% of the global wound evacuators market and this number is likely to further improve during the forecast period.
Within Europe, the United Kingdom and Germany are emerging as the most lucrative markets for wound evacuators due to the increasing incidence of chronic wounds and rising spending on wound care. For instance, as per GOV.UK, there are over 2.2 million people with chronic wounds in the country. Similarly, as per a report published in the Journal of the European Wound Management Association (EWMA Journal), around 0.24% of the population in Germany is affected by chronic wounds. Driven by this, sales of wound evacuators are projected to grow at a considerable pace in the region during the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over the years, the field of wound care has witnessed huge developments and advancements from traditional wound management methods to novel ones like negative pressure wound therapy. This has raised interest among various companies to try their hands at manufacturing wound care therapeutics and devices. As a result, there has been a sharp rise in the number of wound-care start-ups that offer a variety of wound management devices like wound evacuators. For instance,
Some of the key wound evacuator manufacturers include Zimmer, Medline Industries, Inc., C. R. Bard, Inc., Redax, Aspen Surgical (sub. Hill-Rom Company), Argon Medical Devices, Inc., and Plasti-med Medikal Ürünler San. Tic. Ltd. among others. These leading players are continuously adopting strategies such as new product launches, mergers, acquisitions, collaborations, and mergers to gain a competitive edge in the global wound evacuators market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.1% from 2022 to 2032 |
| Market Value in 2022 | US$ 383.3 Million |
| Market Value in 2032 | US$ 593.6 Million |
| Base Year for Estimation | 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
As per FMI, the global wound evacuators market size is estimated to reach US$ 383.3Million in 2022
Demand in the global wound evacuators market is expected to grow at a CAGR of 4.1% through 2032
The global wound evacuators market is projected to reach a valuation of US$ 593.3 Million by 2032
North America dominates the global wound evacuators market with a share of around 33.9%.
1. Executive Summary | Wound Evacuators Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Open System
5.3.2. Closed System
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Analysis 2017 to 2021 and Forecast 2022 to 2032, By Wound Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Wound Type, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Wound Type, 2022 to 2032
6.3.1. Chronic Wounds
6.3.2. Pressure Ulcers
6.3.3. Diabetes Foot Ulcers
6.3.4. Venous Ulcers
6.3.5. Acute Wounds
6.3.6. Other Wound Types
6.4. Y-o-Y Growth Trend Analysis By Wound Type, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Wound Type, 2022 to 2032
7. Global Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
8. Global Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. United States of America
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Wound Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Wound Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Wound Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Wound Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Wound Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Wound Type
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia-Pacific
12.2.2. By Product Type
12.2.3. By Wound Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Wound Type
12.3.4. By End User
12.4. Key Takeaways
13. Middle East and Africa Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Product Type
13.2.3. By Wound Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Wound Type
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Analysis
14.1. United States of America
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By Wound Type
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By Wound Type
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By Wound Type
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By Wound Type
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By Wound Type
14.5.2.3. By End User
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By Wound Type
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By Wound Type
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By Wound Type
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By Wound Type
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By Wound Type
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By Wound Type
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By Wound Type
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By Wound Type
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By Wound Type
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By Wound Type
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product Type
14.16.2.2. By Wound Type
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product Type
14.17.2.2. By Wound Type
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Product Type
14.18.2.2. By Wound Type
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Product Type
14.19.2.2. By Wound Type
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Wound Type
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Zimmer
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Becton, Dickinson, and Company
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Medline Industries, Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Aspen Surgical
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Redax
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Argon Medical Devices, Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Plasti-med Medikal Ürünler San. Tic. Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Baxter International
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Medtronic
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. ConvaTec Group PLC
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Wound Evacuators Market
